Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 33.78 and traded as low as GBX 32. Cambridge Cognition shares last traded at GBX 32, with a volume of 3,548 shares.
Cambridge Cognition Price Performance
The stock has a market cap of £14.90 million, a price-to-earnings ratio of -8.42 and a beta of 0.72. The company has a 50-day moving average of GBX 34.95 and a 200-day moving average of GBX 33.78. The company has a debt-to-equity ratio of 92.53, a quick ratio of 0.96 and a current ratio of 0.65.
Cambridge Cognition (LON:COG – Get Free Report) last issued its earnings results on Tuesday, September 2nd. The company reported GBX (2.40) EPS for the quarter. Cambridge Cognition had a negative net margin of 10.07% and a negative return on equity of 68.83%. As a group, equities research analysts predict that Cambridge Cognition Holdings Plc will post 1.0293539 earnings per share for the current year.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
See Also
- Five stocks we like better than Cambridge Cognition
- Where to Find Earnings Call Transcripts
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- Airline Stocks – Top Airline Stocks to Buy Now
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
